SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors anticipate a pivotal clinical trial catalyst, creating intense pressure on a high number of trapped short positions. The community is actively discussing the scarcity of available shares to borrow, potential buyout scenarios, and expectations for a major upward price move following the upcoming clinical data release.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant volatility driven by institutional rebalancing ahead of the new month and investor debate over the long-term impact of new memory capacity announcements from international competitors. While many in the community are focused on massive price targets supported by recent analyst upgrades and strong earnings, others remain concerned about potential supply gluts and ongoing market rotation into other tech sectors.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is attracting significant market attention and heavy volume as investors speculate on a potential Russell 1000 index inclusion and the long-term impact of its ANKTIVA therapy. The community is actively debating the stock's future, highlighting a high-stakes tug-of-war between bullish long-term shareholders focused on clinical milestones and short sellers betting against the stock's current price momentum.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is capturing significant market attention as a leading player in physical AI, with strong community interest driven by recent contract wins and the integration of its LiDAR sensors into autonomous robotics and smart infrastructure. Investors are actively discussing the company's role as a critical 'picks-and-shovels' provider for the robotics revolution, highlighting recent supply agreements and its expansion into high-volume manufacturing as key catalysts for growth.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing significant selling pressure as investors grapple with sector-wide volatility and ongoing insider share sales, despite recent positive analyst initiations and index inclusion. The community remains deeply divided, with many debating whether the stock is a high-growth AI infrastructure play reaching a technical bottom or a heavily leveraged bet experiencing a structural correction.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is experiencing significant volatility driven by intense short-interest speculation, index rebalancing outflows, and mixed reactions to its proposed Cox merger and SpaceX partnership rumors. The community remains deeply divided, with some investors betting on a short squeeze fueled by aggressive share buybacks and undervalued cash flows, while skeptical traders point to mounting debt concerns, customer churn, and a multi-year downtrend in the share price.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors weigh recent strategic partnerships with Google Cloud and AWS against a volatile trading range and lingering skepticism around its transition from legacy telecom to AI infrastructure. Community discussion remains polarized, with many traders focusing on potential upside from AI-RAN deployments and institutional accumulation, while others express frustration over persistent sell-side pressure and chart patterns.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors weigh strong institutional accumulation and partnership catalystsnotably a high-value collaboration with Jazz Pharmaceuticalsagainst the stock's recent volatility and ongoing short interest. The community remains sharply divided, with bulls highlighting the potential of the ABCL635 pipeline and platform validation, while bears continue to scrutinize the company's historical performance and the risks surrounding upcoming clinical data readouts.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is trending following the announcement of a strategic plan to spin off NBCUniversal and Sky into a separate independent public company to unlock shareholder value. The community is actively debating the merits of this structural separation, with discussions split between those who view it as a necessary catalyst for a valuation re-rating and skeptics who remain focused on broader secular pressures facing the traditional cable and media sector.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is currently facing investor frustration and heightened volatility following a court ruling that upheld the inclusion of its drug Xphozah in the Medicare bundled payment system, effectively denying separate reimbursement. While the community remains divided over management's legal strategy and the resulting share price pressure, many long-term investors are treating the decline as a potential accumulation opportunity, maintaining confidence in the underlying growth of the IBSRELA franchise.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GEVX Valuation sensitivity is high because visibility is uneven; free‑cash‑flow conversion needs to normalize — execution across cycles would support multiple expansion. Markets will follow data, not narratives.

StockTwits Web

Tradr 2X Long GEV Daily ETF

 Valuation sensitivity is high because visibility is uneven; free‑cash‑flow conversion needs to normalize — execution across cycles would support multiple expansion. Markets will follow data, not narratives.